Dec 16, 2022 | Robin Tuohy
Heads up: this blog will not contain any specific abstract information, but rather to give you a bit of history and flavor of the daily schedules for leaders volunteering their time selflessly to bring you their patient perspectives. Please read their blogs for...
Dec 14, 2022 | Becky Bosley
Another ASH comes to a close, and yet again, I am energized and exhausted, simultaneously! Our virtual experience was 10-16 hours a day for 4 days straight, including all of the oral abstract presentations, poster sessions, educational sessions, and working group...
Dec 12, 2022 | Becky Bosley
Saturday at ASH was INTENSE! Virtually taking in content from 7 a.m. until 9:30 p.m. While I’m exhausted, I’m energized at the same time. So much amazing research being done for the good of the patient with myeloma. I think the thing that struck me the most today was...
Dec 12, 2022 | Jessie Daw
For those living with smoldering multiple myeloma (SMM), many uncertainties exist. These uncertainties can be whittled down to two “million dollar” questions: (a) “Will I progress to active disease?” and (b) “Should I consider treatment, and if so, how and when?” This...
Dec 10, 2022 | Jessie Daw
Friday, the first day of the 64th Annual American Society of Hematology (ASH) Annual Meeting, is symposia day. I attended the IMF’s Satellite Symposium, “A Conversation with the Myeloma Experts: Making Sense of the Evolving Treatment Landscape.” The experts were the...
